Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Silicon Laboratories
SLAB
Other Research And Development Expense
Other Research And Development Expense at other companies
Solid Biosciences Inc.
SLDB
$1.98M
-36.4%
OS Therapies
OSTX
$0
—
RFL
Rafael Holdings, Inc.
RFL
$22K
-51.1%
CTO
Citius Oncology, Inc.
CTOR
$469K
-2.3%
TG Therapeutics
TGTX
$87.27M
+218%
TG Therapeutics
TGTX
$87.27M
+218%
Segments
By segment
See full
Reportable Segment
$56.28M
+1.9%
Other financials
Income statement
See full
Revenue
$213.5M
+20.1%
Gross profit
$127.0M
+29.9%
Operating income
-$17.1M
+46.8%
Net income
-$15.9M
+47.8%
EPS (diluted)
-$0.48
+48.9%
Balance sheet
See full
Cash & equivalents
$383.1M
+17.9%
Total debt
$24.0M
+11.8%
Total equity
$1.1B
+2.8%
Total assets
$1.3B
+3.0%
Cash flow
See full
Operating cash flow
$4.9M
-89.7%
CapEx
$9.8M
+103%
Free cash flow
-$4.9M
-111%
Valuation
See full
Market cap
$7.21B
+77.4%
P/S
8.8×
+3.0×
Profitability
See full
Gross margin
59.3%
+5.1pp
Operating margin
-6.8%
-2.7pp
Net margin
-6.1%
-2.6pp
FCF margin
-6.3%
-21.8pp
Returns & leverage
See full
Return on equity
-4.6%
-1.9pp
Debt / equity
0×
0.0×
Current ratio
5.1×
-0.1×
Watchlist
Screener
Filings
Earnings
Charts